Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17859347 | 0.72 | KIF11 (0.46) | KIF11 | |
| SCHEMBL34009 | 0.69 | KIF11 (0.48) | KIF11 | |
| Ethyl(Trityl)Sulfane SCHEMBL4755270 | 0.69 | KIF11 (0.56) | KIF11 | |
| SCHEMBL6130697 | 0.69 | KIF11 (0.56) | KIF11 | |
| SCHEMBL5545280 | 0.69 | KIF11 (0.56) | KIF11 | |
| Ethyl(Trityl)Sulfane SCHEMBL2772809 | 0.67 | KIF11 (0.54) | KIF11 | |
| Benzyl(Trityl)Sulfane SCHEMBL7543647 | 0.67 | KIF11 (0.54) | KIF11 | |
| SCHEMBL29174470 | 0.66 | ACHE (0.44) | KIF11 | |
| SCHEMBL4758138 | 0.65 | KIF11 (0.57) | KIF11 | |
| SCHEMBL15794531 | 0.65 | KIF11 (0.63) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220098155-A1 | NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 | INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE ROUEN (INSA) (FR) | 2022-03-31 | — | — | US | disclosed |
| WO-2020099596-A1 | NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 | UNIVERSITE DE ROUEN NORMANDIE (FR) | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220098155-A1 | NOVEL PATHWAY FOR THE SYNTHESIS OF DIAZIRINES, THAT MAY OR MAY NOT BE ENRICHED IN NITROGEN-15 | SSTR5, SLC6A15, SLC1A5 | KIF11 3071/4885SIRT2 1166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.